Terms: = Sarcomas AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
54 results:
1. LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.
Nielsen M; Monberg T; Sundvold V; Albieri B; Hovgaard D; Petersen MM; Krarup-Hansen A; Met Ö; Camilio K; Clancy T; Stratford R; Sveinbjornsson B; Rekdal Ø; Junker N; Svane IM
Oncoimmunology; 2024; 13(1):2290900. PubMed ID: 38125722
[TBL] [Abstract] [Full Text] [Related]
2. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
Wukich DK; Frykberg RG; Kavarthapu V
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
[TBL] [Abstract] [Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus viral protein kinase augments cell survival.
Wu XJ; Zhang Z; Wong JP; Rivera-Soto R; White MC; Rai AA; Damania B
Cell Death Dis; 2023 Oct; 14(10):688. PubMed ID: 37852997
[TBL] [Abstract] [Full Text] [Related]
4. Risk of obstetric and perinatal complications in women presenting with breast cancer during pregnancy and the first year postpartum in Sweden 1973-2017: A population-based matched study.
Lundberg FE; Gkekos L; Rodriguez-Wallberg KA; Fredriksson I; Johansson ALV
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):684-694. PubMed ID: 36959086
[TBL] [Abstract] [Full Text] [Related]
5. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS; Blattmann C; Borkhardt A; Csóka M; Hassenpflug W; Kabíčková E; Kager L; Kessler T; Kratz C; Kühne T; Kevric M; Lehrnbecher T; Mayer-Steinacker R; Mettmann V; Metzler M; Reichardt P; Rossig C; Sorg B; von Luettichau I; Windhager R; Hecker-Nolting S
Eur J Cancer; 2022 Nov; 176():50-57. PubMed ID: 36191386
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.
Erstad DJ; Chiang YJ; Witt RG; Cope B; Nassif EF; Scally CP; Torres KE; Feig BW; Hunt KK; Bishop AJ; Guadagnolo BA; Roland CL; Keung EZ
Ann Surg Oncol; 2023 Feb; 30(2):926-940. PubMed ID: 36115928
[TBL] [Abstract] [Full Text] [Related]
7. Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.
Srivastava RK; Guroji P; Jin L; Mukhtar MS; Athar M
Mol Carcinog; 2022 Aug; 61(8):737-751. PubMed ID: 35472745
[TBL] [Abstract] [Full Text] [Related]
8. Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
Baldacci S; Besse B; Avrillon V; Mennecier B; Mazieres J; Dubray-Longeras P; Cortot AB; Descourt R; Doubre H; Quantin X; Duruisseaux M; Monnet I; Moro-Sibilot D; Cadranel J; Clément-Duchêne C; Cousin S; Ricordel C; Merle P; Otto J; Schneider S; Langlais A; Morin F; Westeel V; Girard N
Eur J Cancer; 2022 May; 166():51-59. PubMed ID: 35278825
[TBL] [Abstract] [Full Text] [Related]
9. Research Progress of Exosome-Loaded miRNA in Osteosarcoma.
Yao P; Lu Y; Cai Z; Yu T; Kang Y; Zhang Y; Wang X
Cancer Control; 2022; 29():10732748221076683. PubMed ID: 35179996
[TBL] [Abstract] [Full Text] [Related]
10. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study.
Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Kimpo M; Dhamne C; Blair S; Lam C; Photia A; Rujkijyanont P; Traivaree C; Pairojboriboon S; Rodriguez-Galindo C;
Pediatr Blood Cancer; 2022 Apr; 69(4):e29556. PubMed ID: 35038209
[TBL] [Abstract] [Full Text] [Related]
11. An Extensive Presentation of Cutaneous Angiosarcoma.
Ahlers CG; Zwerner JP; Parker ER
J Drugs Dermatol; 2021 Aug; 20(8):895-897. PubMed ID: 34397202
[TBL] [Abstract] [Full Text] [Related]
12. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.
Hasenfratz M; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Roitman PD; Aponte-Tinao LA; Lehner B; Möller P; Mechtersheimer G; Barth TFE
Sci Rep; 2021 Mar; 11(1):5709. PubMed ID: 33707617
[TBL] [Abstract] [Full Text] [Related]
13. Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients.
Cybulska-Stopa B; Ziętek M; Kamińska-Winciorek G; Czarnecka AM; Piejko K; Galus Ł; Ziółkowska B; Kieszko S; Kempa-Kamińska N; Calik J; Zemełka T; Kubiatowski T; Suwiński R; Mackiewicz J; Rutkowski P
Melanoma Res; 2021 Feb; 31(1):49-57. PubMed ID: 33165240
[TBL] [Abstract] [Full Text] [Related]
14. Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
Benito V; Lubrano A; León L; Molano F; Pinar B
Int J Gynecol Cancer; 2020 Nov; 30(11):1726-1732. PubMed ID: 32948637
[TBL] [Abstract] [Full Text] [Related]
15. Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group.
Lautz TB; Chi YY; Tian J; Gupta AA; Wolden SL; Routh JC; Casey DL; Dasgupta R; Hawkins DS; Rodeberg DA
Int J Cancer; 2020 Sep; 147(5):1419-1426. PubMed ID: 32012255
[TBL] [Abstract] [Full Text] [Related]
16. Aurora A Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death.
Ommer J; Selfe JL; Wachtel M; O'Brien EM; Laubscher D; Roemmele M; Kasper S; Delattre O; Surdez D; Petts G; Kelsey A; Shipley J; Schäfer BW
Cancer Res; 2020 Feb; 80(4):832-842. PubMed ID: 31888889
[TBL] [Abstract] [Full Text] [Related]
17. Can clinical radiomics nomogram based on 3D multiparametric MRI features and clinical characteristics estimate early recurrence of pelvic chondrosarcoma?
Yin P; Mao N; Liu X; Sun C; Wang S; Chen L; Hong N
J Magn Reson Imaging; 2020 Feb; 51(2):435-445. PubMed ID: 31215096
[TBL] [Abstract] [Full Text] [Related]
18. Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
Younger E; Ballman K; Lu Y; Pápai Z; Van Tine BA; Attia S; Schöffski P; Reinke D; Tap WD; Jones RL
J Geriatr Oncol; 2020 Apr; 11(3):463-469. PubMed ID: 31126845
[TBL] [Abstract] [Full Text] [Related]
19. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F
Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835
[TBL] [Abstract] [Full Text] [Related]
20. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
[TBL] [Abstract] [Full Text] [Related]
[Next]
